Andrew J. Greenfield, VP, Chief Commercial Officer at ABIOMED INC (ABMD), sold 5,000 shares at $366.00 ($1.8M) on 2021-01-28, disclosed to the SEC on 2021-02-01.
Seasonal sale ($1.8M) by VP, Chief Commercial Officer — this insider has traded ABMD in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ABMD | SELL | 2018-09-26 | $2.1M | — | Filing → |
| ABMD | SELL | 2018-08-31 | $1.8M | — | Filing → |
| ABMD | SELL | 2018-02-22 | $7.7M | — | Filing → |